(EXEL) Exelixis - Performance 77.4% in 12m
Compare EXEL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
41.68%
#11 in Group
Rel. Strength
94.12%
#470 in Universe
Total Return 12m
77.38%
#18 in Group
Total Return 5y
51.74%
#29 in Group
P/E 21.8
64th Percentile in Group
P/E Forward 17.0
67th Percentile in Group
PEG 2.27
88th Percentile in Group
FCF Yield 6.74%
94th Percentile in Group
12m Total Return: EXEL (77.4%) vs XBI (-5.4%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
| HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
| AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
| LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
| BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
| ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
| BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: EXEL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for EXEL
| Total Return (including Dividends) | EXEL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.87% | 5.55% | -0.45% |
| 3 Months | 18.28% | -9.75% | -6.29% |
| 12 Months | 77.38% | -5.39% | 13.04% |
| 5 Years | 51.74% | -13.20% | 111.82% |
| Trend Score (consistency of price movement) | EXEL | XBI | S&P 500 |
| 1 Month | 72.2% | 70% | 47.5% |
| 3 Months | 36.2% | -88.1% | -87.3% |
| 12 Months | 92.3% | -44.4% | 54.3% |
| 5 Years | 27.2% | -53.6% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #104 | 1.25% | 7.35% |
| 3 Month | #22 | 31.1% | 26.2% |
| 12 Month | #19 | 87.5% | 56.9% |
| 5 Years | #29 | 74.8% | -28.4% |
FAQs
Does EXEL Exelixis outperforms the market?
Yes,
over the last 12 months EXEL made 77.38%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months EXEL made 18.28%, while XBI made -9.75%.
Over the last 3 months EXEL made 18.28%, while XBI made -9.75%.
Performance Comparison EXEL vs Indeces and Sectors
EXEL vs. Indices EXEL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.36% | 7.32% | 15.6% | 64.3% |
| US NASDAQ 100 | QQQ | 1.44% | 4.97% | 14.9% | 62.4% |
| US Dow Jones Industrial 30 | DIA | 2.90% | 9.72% | 16.3% | 68.1% |
| German DAX 40 | DAX | 2.72% | 7.09% | -2.53% | 52.4% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.01% | 10.1% | 19.3% | 72.4% |
| Hongkong Hang Seng | HSI | 2.76% | 8.39% | 15.0% | 64.5% |
| India NIFTY 50 | INDA | 4.88% | 1.99% | 15.7% | 74.5% |
| Brasil Bovespa | EWZ | 3.99% | 4.04% | 9.86% | 84.1% |
EXEL vs. Sectors EXEL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.21% | 7.47% | 9.58% | 53.9% |
| Consumer Discretionary | XLY | 2.33% | 7.46% | 14.4% | 62.7% |
| Consumer Staples | XLP | 4.42% | 7.69% | 11.5% | 66.4% |
| Energy | XLE | 6.62% | 20.9% | 20.7% | 86.7% |
| Financial | XLF | 3.47% | 8.88% | 8.63% | 54.7% |
| Health Care | XLV | 5.06% | 11.5% | 20.7% | 78.6% |
| Industrial | XLI | 2.04% | 6.57% | 14.5% | 66.7% |
| Materials | XLB | 4.17% | 10.1% | 23.4% | 81.8% |
| Real Estate | XLRE | 2.47% | 7.97% | 15.4% | 59.0% |
| Technology | XLK | 0.80% | 4.44% | 18.5% | 66.9% |
| Utilities | XLU | 3.64% | 6.77% | 11.1% | 56.6% |
| Aerospace & Defense | XAR | 1.33% | -0.11% | 1.68% | 49.9% |
| Biotech | XBI | 2.52% | 1.32% | 30.9% | 82.8% |
| Homebuilder | XHB | 3.63% | 8.95% | 30.5% | 83.6% |
| Retail | XRT | 3.60% | 8.03% | 21.5% | 78.9% |